In one of the very first reports of the clinical course of COVID-19 patients, as early as March 2020, serum increase in interleukin (IL)-2, IL-7, GMCSF, IP-10, MCP 1, MIP1-α, and TNF-α was associated to disease severity [5]. Here, IL2 is linked to COVID-19.